Neuronetics Adds Two Directors to Board
Ticker: STIM · Form: 8-K · Filed: Mar 4, 2025 · CIK: 1227636
| Field | Detail |
|---|---|
| Company | Neuronetics, Inc. (STIM) |
| Form Type | 8-K |
| Filed Date | Mar 4, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: board-composition, governance, officer-compensation
TL;DR
Neuronetics adds two new directors to the board, effective Feb 24, 2025.
AI Summary
Neuronetics, Inc. announced on February 24, 2025, a change in its board of directors. Specifically, the company elected two new directors, Dr. David M. D. Smith and Mr. David L. Johnson, to its Board of Directors, effective February 24, 2025. This filing also disclosed compensatory arrangements for certain officers.
Why It Matters
The election of new directors can signal a shift in company strategy or governance, potentially impacting future performance and investor confidence.
Risk Assessment
Risk Level: low — This filing primarily concerns board composition changes and compensatory arrangements, which are routine corporate governance events.
Key Players & Entities
- Neuronetics, Inc. (company) — Registrant
- Dr. David M. D. Smith (person) — Newly elected director
- Mr. David L. Johnson (person) — Newly elected director
- February 24, 2025 (date) — Effective date of director election
FAQ
Who were the new directors elected to Neuronetics' Board?
Dr. David M. D. Smith and Mr. David L. Johnson were elected as new directors.
When was the election of the new directors effective?
The election of the new directors was effective on February 24, 2025.
What other information is disclosed in this 8-K filing?
The filing also discloses compensatory arrangements of certain officers.
What is Neuronetics, Inc.'s principal executive office address?
Neuronetics, Inc.'s principal executive offices are located at 3222 Phoenixville Pike, Malvern, PA 19355.
What is the SIC code for Neuronetics, Inc.?
The Standard Industrial Classification (SIC) code for Neuronetics, Inc. is 3841, which corresponds to Surgical & Medical Instruments & Apparatus.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 4, 2025 by Dr. David M. D. Smith regarding Neuronetics, Inc. (STIM).